Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions

Antibody drug conjugates (ADCs) are novel medications that combine monoclonal antibodies with cytotoxic payloads, enabling the selective delivery of potent drugs to cancer cells expressing specific surface antigens. This targeted strategy seeks to optimize treatment effectiveness while reducing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mark, Cynthia, Lee, Jin Sun, Cui, Xiaojiang, Yuan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531043/
https://www.ncbi.nlm.nih.gov/pubmed/37762027
http://dx.doi.org/10.3390/ijms241813726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531043/
https://www.ncbi.nlm.nih.gov/pubmed/37762027
http://dx.doi.org/10.3390/ijms241813726

Ejemplares similares